Obesity medicine · 2026
Weight loss in China,
medication to surgery, one pathway.
GLP-1 medications from $280/month, endoscopic procedures, and bariatric surgery from $9,500 — matched to your BMI and comorbidities at Class A metabolic centres. Multidisciplinary workup, bilingual reports, and a follow-up plan your home physician can run.
$280/mo
GLP-1 (semaglutide)
Wegovy 2.4mg vs ~$1,350 US list (~80% off)
NMPA-listed pricing 2024
$420/mo
GLP-1 (tirzepatide)
10–15mg titration dose vs ~$1,080 US
NMPA-listed pricing 2024
$9,500+
Sleeve gastrectomy
All-in vs $15,000–25,000 US private
Partner-hospital quotes 2024
25–35%
Total weight loss (surgery)
At 1–2 years, durable for most patients
IFSO / bariatric literature
Class A
Metabolic centres
CSMBS / IFSO-recognised bariatric programs
NHC ratings
MDT
Endocrine + nutrition + psych
Multidisciplinary workup is standard
IFSO guidelines
Tiers & pricing
One ladder, from medication to surgery.
Medical weight management
Endocrinology consult, metabolic labs, structured nutrition + resistance-training prescription, body-composition baseline. The foundation under every other tier.
$650–1,250 first visit
GLP-1 medication
Semaglutide (~14–17% loss) or tirzepatide (~21% loss). NMPA-approved, hospital-pharmacy dispensed, bilingual prescription + customs letter.
$280–420 / month
Endoscopic options
Intragastric balloon or ESG (endoscopic sleeve gastroplasty) — non-surgical, for patients not meeting or not wanting surgical criteria.
$5,500–9,500
Sleeve gastrectomy
Laparoscopic vertical sleeve — the most common bariatric operation. ~25–30% total weight loss at 1 year. Lower reoperation than bypass.
$9,500–13,500
Gastric bypass / SADI-S
RYGB and SADI-S for severe type 2 diabetes and higher BMI. Strongest diabetes-remission and long-term durability profile.
$12,000–19,000
Revision surgery
Sleeve-to-bypass or sleeve-to-SADI-S revision for inadequate weight loss, weight regain, or refractory reflux.
$14,000–22,000
Top hospitals
Six centres
open to international patients.
Shanghai Sixth People's Hospital 上海第六人民医院
National reference for diabetes and obesity surgery · MDT metabolic program
Peking University People's Hospital 北京大学人民医院
Class A teaching · high-volume sleeve and bypass · CSMBS-recognised
Zhongshan Hospital, Fudan University 中山医院
Class A · academic centre · revision surgery experience
First Affiliated Hospital, Sun Yat-sen University 中山一院
Class A · regional reference for metabolic and bariatric surgery
Beijing Friendship Hospital 北京友谊医院
Class A · strong metabolic surgery program · MDT obesity clinic
United Family Hospitals 和睦家
JCI · expat-focused · endocrinology-led GLP-1 and medical weight management
Cost comparison
China vs US vs UK,
real weight-loss pricing.
Sources: NMPA-listed pharmacy pricing 2024, ASMBS / Healthcare Bluebook 2024, NHS / Bupa UK 2024, partner-hospital itemized quotes 2024–2025. GLP-1 pricing is per-month medication only; surgical pricing is all-in and excludes airfare, accommodation and complications. Educational only — not medical advice.
FAQ
Weight loss in China — answered.
- Medication or surgery — which is right for me?
- It depends on your BMI and comorbidities. For BMI 27–35 without significant comorbidity, GLP-1 medication (semaglutide or tirzepatide) is typically first-line and achieves 14–21% weight loss while taken. For BMI ≥ 35 with comorbidities, or BMI ≥ 40, bariatric surgery has the strongest long-term durability evidence (25–35% total weight loss sustained at 5+ years) — though many patients trial GLP-1 first. Endoscopic options (balloon, ESG) sit in between for BMI 27–35 who want a procedure without surgery. We match a recommendation to your profile after an endocrinology and, where relevant, surgical assessment.
- How much does weight loss treatment cost in China?
- GLP-1 medication runs ~$280/month for semaglutide (Wegovy) or ~$420/month for tirzepatide — roughly 60–80% below US list prices — plus a $650–1,250 first-visit workup package. Endoscopic options (balloon / ESG) are $5,500–9,500. Bariatric surgery is all-in $9,500–13,500 for sleeve, $12,000–16,500 for gastric bypass, and $14,500–19,000 for SADI-S. Surgical quotes include surgeon, anaesthesia, ward stay and pre-op workup; they exclude airfare, accommodation and complications cover.
- Are semaglutide and tirzepatide legally available in China?
- Yes. Semaglutide (Ozempic) was NMPA-approved for type 2 diabetes in 2021 and Wegovy 2.4mg for chronic weight management in mid-2024. Tirzepatide was approved for T2D in mid-2024 and for weight management in late-2024 / early-2025. Both are dispensed by Class A hospital pharmacies with a bilingual prescription and a physician's letter for customs. A domestic GLP-1 (beinaglutide) is also NMPA-indicated for obesity. See our GLP-1 guide for the full pricing and supply picture.
- How much weight will I actually lose?
- Honest ranges from registry and phase-3 data: semaglutide 2.4mg ~14–17% of body weight at 68 weeks; tirzepatide 15mg ~21% at 72 weeks; sleeve gastrectomy ~25–30% total weight loss at 1 year; gastric bypass / SADI-S ~30–35%. Individual response varies and most loss occurs in months 3–12. Whether that loss preserves lean mass depends on nutrition and resistance training — we bundle a structured prescription and re-check body composition at 6 and 12 months.
- What happens if I stop GLP-1 medication?
- Most patients regain a substantial share of the weight after stopping GLP-1s — these are treatments for a chronic condition, not a course you finish. That is a key reason patients with higher BMI and comorbidities often move to bariatric surgery, which produces more durable loss. If you take the medication route, plan for long-term maintenance and confirm a home-country prescriber before you rely on it. We provide a bilingual medication and follow-up plan for that handover.
- Who is eligible for bariatric surgery, and what does follow-up require?
- Eligibility follows IFSO criteria: broadly BMI ≥ 32.5 with metabolic disease (T2D, severe sleep apnoea, fatty liver) or BMI ≥ 37.5 without comorbidity, age 18–65 (some centres to 70 with screening), able to commit to lifelong follow-up and free of untreated psychiatric illness or active substance abuse. Surgery requires lifelong supplementation (multivitamin, B12, vitamin D, calcium, iron) and scheduled labs. Before travelling, you must confirm a home-country physician or dietitian to manage long-term follow-up; we supply a bilingual operative note, nutrition plan and lab schedule.
Related guides
GLP-1 Medications
Semaglutide & tirzepatide — full 2026 pricing, supply and workup.
Read the guideBariatric Surgery
Sleeve, bypass, SADI-S and revision — eligibility and all-in cost.
Read the guideSleeve Cost by City
City-by-city sleeve gastrectomy pricing.
Read the guideMetabolic Health Check
Baseline workup — labs, body composition, comorbidity screen.
Read the guideCost Comparison
China vs US vs UK across procedures and medications.
Read the guideSecond Opinion
Independent obesity-medicine second opinion from $250.
Read the guideSend your BMI and labs
for a written pathway.
Share your BMI, comorbidities and recent labs. We return a written recommendation from a partner endocrinologist or bariatric surgeon — which of the medication, endoscopic and surgical paths fit your case, with indicative cost and a follow-up plan for your home team.
This page is for general information only and does not constitute medical advice. Obesity is a chronic condition; no treatment guarantees a specific weight loss, and medication weight loss is typically regained if treatment stops. GLP-1 medications and bariatric surgery both carry risks reviewed by the treating physician. All clinical decisions are made by the treating physician at the partner hospital after assessment.
Published 26 July 2026 · Editorial policy